GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacos Pharmaceuticals Inc (GREY:PANC) » Definitions » Change In Receivables

Panacos Pharmaceuticals (Panacos Pharmaceuticals) Change In Receivables : $0.03 Mil (TTM As of Sep. 2008)


View and export this data going back to 1998. Start your Free Trial

What is Panacos Pharmaceuticals Change In Receivables?

Panacos Pharmaceuticals's change in receivables for the quarter that ended in Sep. 2008 was $-0.02 Mil. It means Panacos Pharmaceuticals's Accounts Receivable increased by $0.02 Mil from Jun. 2008 to Sep. 2008 .

Panacos Pharmaceuticals's change in receivables for the fiscal year that ended in Dec. 2007 was $-0.08 Mil. It means Panacos Pharmaceuticals's Accounts Receivable increased by $0.08 Mil from Dec. 2006 to Dec. 2007 .

Panacos Pharmaceuticals's Accounts Receivable for the quarter that ended in Sep. 2008 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Panacos Pharmaceuticals's Days Sales Outstanding for the three months ended in Sep. 2008 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Panacos Pharmaceuticals's liquidation value for the three months ended in Sep. 2008 was $2.42 Mil.


Panacos Pharmaceuticals Change In Receivables Historical Data

The historical data trend for Panacos Pharmaceuticals's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacos Pharmaceuticals Change In Receivables Chart

Panacos Pharmaceuticals Annual Data
Trend Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.05 -0.14 0.11 0.32 -0.08

Panacos Pharmaceuticals Quarterly Data
Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.09 -0.01 0.03 0.04 -0.02

Panacos Pharmaceuticals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Panacos Pharmaceuticals  (GREY:PANC) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Panacos Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Sep. 2008 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/0.024*91
=0.00

2. In Ben Graham's calculation of liquidation value, Panacos Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:

Panacos Pharmaceuticals's liquidation value for the quarter that ended in Sep. 2008 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=26.888-24.466+0.75 * 0+0.5 * 0
=2.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Panacos Pharmaceuticals Change In Receivables Related Terms

Thank you for viewing the detailed overview of Panacos Pharmaceuticals's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Panacos Pharmaceuticals (Panacos Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
134 Coolidge Avenue, Watertown, MA, USA, 02472
Panacos Pharmaceuticals Inc is a biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat HIV and other human viral diseases.

Panacos Pharmaceuticals (Panacos Pharmaceuticals) Headlines

No Headlines